Loading data for GOVX — first visit, this takes a few seconds.
GeoVax Labs, Inc. (GOVX)
NasdaqCM: GOVX
· Real-Time Price · USD
0.72
+0.00 (0.00%)
At close: Sep 04, 2026, 3:59 PM
0.55
-0.63%
After-hours: 4:06 PM
The price, the headline numbers and the latest news, in one place.
GeoVax Labs, Inc. (GOVX) Stock Price, Analysis & Data
0.56% (1D)
| Bid | 0.71 |
| Market Cap | 2.88M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | -20.4M |
| 3.66 | |
| -5.62 | |
| n/a | |
| -0.64 | |
| P/B (ttm) | 2.31 |
| P/S (ttm) | 0.00 |
| Earnings Date | n/a |
| Ask | 0.89 |
| Volume | 742,690 |
| Avg. Volume (20D) | 741,814 |
| Open | 0.70 |
| Previous Close | 0.72 |
| Day's Range | 0.68 - 0.73 |
| 52-Week Range | 0.59 - 19.20 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About GOVX
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. It develops GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the t...
Industry Biotechnology
Sector Healthcare
IPO Date Sep 25, 2020
Employees 19
Stock Exchange NasdaqCM
Ticker Symbol GOVX
Website https://www.geovax.com
Financial Performance
In 2025, GeoVax Labs's revenue was 2.49M, a decrease of -37.06% compared to the previous year's 3.95M. Earnings were -21.46M, a decrease of -14.11%.
Financial StatementsEarnings Surprise
GeoVax Labs has released their quarterly earnings on Invalid Date:
- Revenue of n/a misses estimates by $0, with NaN% YoY growth.
- EPS of misses estimates by , with NaN% YoY growth.